Coronary Heart Disease Diagnostic Imaging Devices Market – By Modality (CT, X-Ray, Ultrasound, Nuclear Medicine), Application (Arrhythmia, Heart Attack, Heart Failure), End-Use (Hospitals, Diagnostic Imaging Centers) – Global Forecast, 2024 – 2032

Coronary Heart Disease Diagnostic Imaging Devices Market Size

Coronary Heart Disease Diagnostic Imaging Devices Market size was valued at around USD 1.8 billion in 2023 and is estimated to grow at 6.6% CAGR from 2024 to 2032. Coronary heart disease diagnostic imaging devices are medical tools used to visualize and assess the condition of the coronary arteries and the heart. These devices help detect blockages, abnormalities, and other issues that can lead to coronary heart disease (CHD).
 

The increasing prevalence of coronary heart disease is a significant catalyst for market growth. For instance, according to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, taking an estimated 17.9 million lives each year. More than four out of five cardiovascular disease deaths are due to heart attacks and strokes, and one-third of these deaths occur primarily in people under 70 years of age. Thus, this increasing prevalence of coronary heart disease underscores the heightened need for superior treatment options, directly fueling demand in the market.
 

Furthermore, increased awareness about the risks and symptoms of coronary heart disease is leading to more proactive health check-ups and early diagnosis. Early detection is crucial in managing CHD, accelerating the demand for diagnostic imaging devices.
 

Coronary Heart Disease Diagnostic Imaging Devices Market Trends

• Continuous advancements in imaging technology, such as the development of high-resolution and 3D imaging systems, are enhancing the accuracy and reliability of coronary heart disease diagnoses. These technological innovations are propelling market growth by providing more precise and non-invasive diagnostic options.
   
• Moreover, there is a rising preference for non-invasive diagnostic methods, which are safer and more comfortable for patients. Non-invasive imaging technologies, such as CT scanners and MRI, are increasingly being adopted, further boosting the market.
   

Coronary Heart Disease Diagnostic Imaging Devices Market Analysis

Based on modality, the market is segmented into computed tomography (CT), x-ray, ultrasound, magnetic resonance imaging (MRI), and nuclear medicine. The computed tomography segment is forecasted to reach USD 443.8 million by 2032.
 

• CT scans offer high-resolution imaging that is crucial for visualizing the coronary arteries and detecting blockages or narrowing with major detail. This detailed and accurate information about a patient’s cardiac health condition enables doctors and healthcare professionals to provide appropriate treatment, leading to enhanced outcomes and thus propelling market growth.
   
• Additionally, technological advancements, such as the development of multi-slice CT scanners and dual-energy CT, are enhancing the capabilities of CT imaging, further propelling its adoption in clinical settings.

Based on application, the coronary heart disease diagnostic imaging devices market is bifurcated into arrhythmia, heart attack, heart failure, congenital heart conditions, and other applications. The heart attack segment accounted for USD 585.7 million in 2023.
 

• The increasing global incidence of heart attacks, driven by rising risk factors such as hypertension, obesity, diabetes, and unhealthy lifestyles, is significantly boosting the demand for advanced diagnostic imaging tools.
   
• Early and accurate detection of heart attacks is critical for effective treatment and patient outcomes, making medical imaging, indispensable in emergency and clinical settings.
   
• Additionally, growing awareness about the importance of early diagnosis and intervention is leading to more widespread use of imaging technologies in both preventive screening and post-heart attack monitoring.
   
• These factors, combined with increased healthcare spending and initiatives to reduce cardiovascular mortality rates, are expected to propel the heart attack segment's market growth substantially over the forecast period.
   

Based on end-use, the coronary heart disease diagnostic imaging devices market is bifurcated into hospitals, diagnostic imaging centers, ambulatory surgical centers (ASCs), and other end-users. The hospitals segment accounted for USD 742.1 million in 2023.
 

• Hospitals offer a wide range of services for cardiovascular diseases, including diagnostic imaging services, therapeutic interventions, emergency care, and long-term management. This results in a high volume of diagnostic imaging procedures and efficient treatment for patients, which eventually leads to widespread adoption and substantial market expansion.
   
• • Furthermore, hospitals are equipped with the latest and most advanced diagnostic imaging technologies, such as high-resolution CT scanners, MRI machines, and advanced ultrasound systems, driving higher trust and credibility and contributing to market growth.

The growth of the coronary heart disease diagnostic imaging devices market in the U.S. is projected to reach USD 1.3 billion by 2032.
 

• Coronary heart disease remains a leading cause of death in the U.S. According to the Centers for Disease Control and Prevention (CDC), heart disease accounts for one in every five deaths in the country. In 2021, roughly 695,000 Americans died from heart disease, with around 375,500 of these deaths attributed to coronary artery disease (CAD), the most common type of heart disease.
   
• The increasing incidence of coronary heart disease is influenced by factors such as aging, poor diet, lack of physical activity, and smoking. Thus, these factors drive the growing need for diagnostic imaging devices to detect and manage the condition at an early stage.
   

The coronary heart disease diagnostic imaging devices market in UK is expected to experience significant and promising growth from 2024 to 2032.
 

• Increased awareness about coronary heart disease and the importance of early diagnosis is leading to higher demand for diagnostic imaging. Public health campaigns and education programs are encouraging individuals to seek regular screenings in the country.
   
• Moreover, according to the British Heart Foundation, approximately 49,000 people under the age of 75 die from heart and circulatory diseases in the UK each year. Additionally, these diseases account for about 27% of all deaths in the country, totaling over 170,000 fatalities annually equivalent to roughly 480 deaths per day, or one every three minutes. This data underscores the increasing need for effective diagnostic methods and treatment options, thereby propelling the market growth in the country.
   

Japan coronary heart disease diagnostic imaging devices market is anticipated to witness lucrative growth between 2024 – 2032.
 

• Japan, known for its advanced healthcare infrastructure and high standards of medical care, represents a significant market for coronary heart disease diagnostic imaging devices. The country invests heavily in research and development across multiple sectors, including healthcare technology. This substantial investment fosters innovation in diagnostic imaging devices, resulting in advanced solutions with enhanced functionality and effectiveness.
   

The coronary heart disease diagnostic imaging devices market in Saudi Arabia is expected to experience growth from 2024 to 2032.
 

• The expansion of hospitals and specialized cardiac centers in Saudi Arabia, along with the growth of private healthcare providers, is driving increased demand for advanced coronary heart disease diagnostic imaging devices.
   
• New healthcare facilities are being equipped with the latest imaging technologies to provide state-of-the-art care, while private hospitals and clinics are investing in these advanced tools to enhance their services and attract more patients.
   
• Thus, this combination of public and private sector investments is significantly contributing to the growth of the diagnostic imaging market in the country.
   

Coronary Heart Disease Diagnostic Imaging Devices Market Share

The coronary heart disease diagnostic imaging devices industry is characterized by intense competition, involving both major global companies and smaller to medium-sized firms vying for market dominance. Key to market strategy is the consistent launch of innovative products utilizing various technologies. Major industry leaders play a significant role in driving innovation through substantial investments in research and development. Moreover, strategic partnerships, acquisitions, and mergers are crucial in strengthening market positions and enhancing international presence.
 

Coronary Heart Disease Diagnostic Imaging Devices Market Companies

Some of the eminent market participants operating in the market industry include:

• Canon Inc.
• Carestream Health
• CHISON Medical Technologies Co., Ltd.
• Esaote SPA
• FUJIFILM Holdings Corporation
• GE HealthCare Technologies Inc.
• Koninklijke Philips N.V.
• Neusoft Corporation
• Samsung Electronics Co., Ltd.
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Shimadzu Corporation
• Siemens Healthineers AG
• Ziehm Imaging GmbH.
   

Coronary Heart Disease Diagnostic Imaging Devices Industry News:

• In May 2024, GE HealthCare and Medis Medical Imaging, a leading provider of cardiac imaging software, announced a partnership to enhance precision care in diagnosing and treating coronary artery disease (CAD). This collaboration aims to advance the development and commercialization of Medis Quantitative Flow Ratio (Medis QFR), a non-invasive method for assessing coronary physiology. Integrated into GE HealthCare’s Allia Platform, the collaboration will focus on incorporating emerging technologies such as Medis QFR and streamlining procedures in the catheterization lab to improve the operating environment for clinicians.
   
• In February 2024, Philips achieved a major milestone with over 1,500 Cath Lab installations across the Indian Subcontinent, advancing its goal to improve health outcomes, enhance patient and staff experiences, and lower care costs. The recent deployment of Azurion Cath Labs in major cities such as Delhi, Bangalore, Mumbai, and others highlighted Philips' dedication to innovative and efficient healthcare solutions. This extensive installation network boosted Philips' brand visibility and solidified its reputation as a leading provider of advanced imaging solutions.
   

The coronary heart disease diagnostic imaging devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Modality

• Computed tomography (CT)                  
• X-ray           
• Ultrasound              
• Magnetic resonance imaging (MRI)                   
• Nuclear medicine

Market, By Application

• Arrhythmia
• Heart attack
• Heart failure                              
• Congenital heart conditions
• Other applications    

Market, By End-use

• Hospitals                
• Diagnostic imaging centers
• Ambulatory surgical centers (ASCs)        
• Other end-users

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America 
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa